Tecan Ag Hombr N Akt (TCHBF) 102.0000 $TCHBF
Tecan to present at J.P. Morgan Healthcare Conference
Thomson Reuters ONE - Thu Jan 08, 12:25AM CST
Tecan Group AG / Tecan to present at J.P. Morgan Healthcare Conference . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
JPM: 59.67 (+0.10)
2014-2018 US Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers
M2 - Mon Dec 08, 8:27AM CST
Research and Markets (http://www.researchandmarkets.com/research/vf9r39/20142018_us) has announced the addition of the "2014-2018 US Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers" report to their offering. This unique report provides US sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Caliper - Cepheid - Decode - Diadexus - Eiken - Enzo - Exact Sciences - Grifols - Illumina - Kreatech - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Proteome Sciences - Qiagen - Roche - Takara Bio - Tecan Group For more information visit http://www.researchandmarkets.com/research/vf...0142018_us
MYGN: 34.03 (+0.40), A: 40.15 (+0.13), CPHD: 59.62 (+0.72), DHR: 86.81 (+0.21)
2014-2018 US Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers
M2 - Mon Dec 08, 8:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/mz6ptk/20142018_us) has announced the addition of the "2014-2018 US Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers" report to their offering. This unique report provides US sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Company Profiles - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Decode - Diadexus - Eiken - Enzo - Exact Sciences - Illumina - Kreatech - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Nanogen/Elitech - Orchid CellMark - Ortho-Clinical Diagnostics - Proteome Sciences - Qiagen - Roche - Siemens - Sierra Molecular - Takara Bio - Tecan Group For more information visit http://www.researchandmarkets.com/research/mz...0142018_us
MYGN: 34.03 (+0.40), A: 40.15 (+0.13), DHR: 86.81 (+0.21)
Tecan issues H2 2014 trading update
Thomson Reuters ONE - Mon Dec 01, 12:15AM CST
Tecan Group AG / Tecan issues H2 2014 trading update . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
Global High Throughput Screening (HTS) Market 2014-2018: Key Vendors are Agilent, Bio-Rad, Danaher, PerkinElmer, Sigma-Aldrich and Thermo Fisher
M2 - Thu Oct 09, 2:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qzqwwb/global_high) has announced the addition of the "Global High Throughput Screening (HTS) Market 2014-2018" report to their offering. High throughput screening (HTS) is a technology of screening and analyzing a large number of biological or chemical compounds against specific targets. It is generally a fully automated technology and involves instruments, consumables, and software for screening and analysis of compound. The use of liquid handling devices, robotics, and bioinformatics are important aspects of the HTS technology. It is widely used by researchers for drug discovery and other research applications. The high sensitivity, high speed, and easy to use supports the adoption of HTS in research and drug discovery to identify enzymes, ligands for receptors, ion-channels, or other pharmacological targets of interest. HTS is a crucial step in drug discovery for various applications such as assay development, target identification, and primary screening. The analysts forecast the Global HTS market to grow at a CAGR of 7.85 percent over the period 2013-2018. Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Market Segmentation by Application 08. Market Segmentation by Technology 09. Market Segmentation by Product 10. Geographical Segmentation 11. Buying Criteria 12. Market Growth Drivers 13. Drivers and their Impact 14. Market Challenges 15. Impact of Drivers and Challenges 16. Market Trends 17. Trends and their Impact 18. Vendor Landscape 19. Key Vendor Analysis Companies Mentioned: - Agilent Technologies - Aurora Biomed - Axxam - BMG LABTECH - Becton - Bio-Rad Laboratories - BioFocus DPI - BioTek Instruments - Brooks Automation - Charles River LaboratoriesInternational - Corning - Danaher - Dickinson and Company - DiscoveRx - Dynamic Devices - Evotec - F. Hoffmann-La Roche - Genedata - Intellicyt - Luminex - PerkinElmer - Sigma-Aldrich - Tecan Group - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/qz...lobal_high
A: 40.15 (+0.13), DHR: 86.81 (+0.21), PKI: 46.30 (-0.10)
European Major Molecular Diagnostic Product Suppliers Sales and Market Shares 2014
M2 - Mon Oct 06, 6:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cw28k8/europe_sales_and) has announced the addition of the "Europe Sales and Market Shares of Major Molecular Diagnostic Product Suppliers by Country" report to their offering. This unique report provides Europe sales and market share estimates for major suppliers of molecular diagnostic products by country. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca/Nuvelo - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Decode - Diadexus - Grifols - Hologic/Gen-Probe - Illumina - Kreatech - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group For more information visit http://www.researchandmarkets.com/research/cw..._sales_and
SQNM: 3.62 (unch), MYGN: 34.03 (+0.40), A: 40.15 (+0.13), DHR: 86.81 (+0.21), HOLX: 30.46 (+0.21)
Germany Major Molecular Diagnostic Product Suppliers Report 2014 - Sales and Market Shares Analysis
M2 - Mon Oct 06, 6:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/d86mxx/germany_sales_and) has announced the addition of the "Germany Sales and Market Shares of Major Molecular Diagnostic Product Suppliers" report to their offering. This unique report provides Germany sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Agilent Technologies - Applied Gene Technologies - Arca/Nuvelo - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Cepheid - Diadexus - Enzo - Exact Sciences - Fujirebio/Innogenetics - Grifols - Hologic/Gen-Probe - Illumina - Kreatech - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Nanogen/Elitech - Ortho-Clinical Diagnostics - Proteome Sciences - Qiagen - Roche - Siemens - Takara Bio - Tecan Group For more information visit http://www.researchandmarkets.com/research/d8..._sales_and
MYGN: 34.03 (+0.40), A: 40.15 (+0.13), DHR: 86.81 (+0.21), CPHD: 59.62 (+0.72), HOLX: 30.46 (+0.21)
Japan Major Molecular Diagnostic Product Suppliers Sales and Market Shares 2014
M2 - Fri Oct 03, 9:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zglr3w/japan_sales_and) has announced the addition of the "Japan Sales and Market Shares of Major Molecular Diagnostic Product Suppliers" report to their offering. This unique report provides Japan sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca/Nuvelo - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Caliper - Exact Sciences - Fujirebio/Innogenetics - Grifols - Hologic/Gen-Probe - Illumina - Kreatech - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group For more information visit http://www.researchandmarkets.com/research/zg..._sales_and
SQNM: 3.62 (unch), A: 40.15 (+0.13), DHR: 86.81 (+0.21), HOLX: 30.46 (+0.21)
Tecan announces Capital Markets Day
Thomson Reuters ONE - Wed Sep 10, 12:30AM CDT
Tecan Group AG / Tecan announces Capital Markets Day . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
Drug Discovery Technologies - A Global Market Overview
M2 - Fri Aug 29, 5:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dtdx3f/drug_discovery) has announced the addition of the "Drug Discovery Technologies - A Global Market Overview" report to their offering. The development of new drugs for treating difficult diseases, such as cancer requires extensive expenditure, in addition to consuming a lot of time. The first step in designing a new drug involves the utilizing high-throughput screening of large chemical libraries for identifying compounds that can provide the requisite therapeutic effect. The capability of visualizing biological activity at the cellular level has constituted a strategic component in drug discovery, and adding automation and high-volume screening methods has enabled in testing compounds in large numbers. The field of pharmaceutical research is being provided considerable impetus through the combination of imaging and screening. Key Topics Covered: PART A: GLOBAL MARKET PERSPECTIVE 1. INTRODUCTION 2. KEY MARKET TRENDS 3. RECENT PATENTS IN DRUG DISCOVERY LANDSCAPE 4. KEY GLOBAL PLAYERS 5. KEY BUSINESS TRENDS 6. GLOBAL MARKET OVERVIEW PART B: REGIONAL MARKET PERSPECTIVE 1. THE UNITED STATES 2. EUROPE 3. ASIA-PACIFIC 4. REST OF WORLD PART C: GUIDE TO THE INDUSTRY 1. NORTH AMERICA 2. EUROPE 3. ASIA-PACIFIC 4. REST OF WORLD PART
ANNEXURE 1. RESEARCH METHOLOGY 2. FEEDBACK Companies Mentioned: - 4-Antibody AG - Abbott Laboratories - Accelrys, Inc. - Affymetrix Inc. - Agilent Technologies Inc. - Asahi Kasei Pharma Corporation - Astrazeneca Plc - Aviva Biosciences Corp. - Bayer Healthcare AG - BD Biosciences - Beckman Coulter Inc. - Biacore International AB - Bioanalytical Systems, Inc. - Bio-Rad Laboratories, Inc. - Boehringer Ingelheim GmbH - Bristol-Myers Squibb Company - Caliper Life Sciences, Inc. - Caprion Proteomics, Inc. - Celera Corporation - Celgene Corporation - Charles River Laboratories International, Inc. - Compugen Ltd. - Decode Genetics, Inc. - EMD Millipore Corporation - Evotec AG - GE Healthcare Ltd. - Genedata AG - Hitgen Ltd - Hudson Robotics, Inc. - Illumina Inc. - Incyte Corporation - Isis Pharmaceuticals, Inc. - Kyowa Hakko Kirin Co., Ltd. - Luminex Corporation - Maxcyte, Inc - Merck & Co., Inc. - Millennium Pharmaceuticals, Inc. - Molecular Devices, LLC - Molecular Discovery Ltd. - Molecular Discovery Systems Pty., Ltd. - New England Biolabs, Inc. - Novartis AG - Osiris Therapeutics Inc. - Perkinelmer, Inc. - Promega Corporation - Qiagen N.V. - Quantum Pharmaceuticals - Roche Holding AG - Shimadzu Corporation - Sigma-Aldrich Corporation - Sri Biosciences - Tecan Group Ltd. - The National Center for Drug Screening - Thermo Fisher Scientific Inc. - Viva Biotech Ltd - Waters Corp. For more information visit http://www.researchandmarkets.com/research/dt..._discovery
A: 40.15 (+0.13), OSIR: 15.95 (+0.28), ILMN: 198.54 (+1.81), LMNX: 15.45 (+0.02), AFFX: 11.45 (+0.02), QGEN: 23.68 (-0.06), BCOR: 14.20 (-0.45), ACCL: 12.51 (+0.03), ABT: 46.09 (+0.87), INCY: 75.94 (+0.28), BMY: 60.04 (+0.56), WAT: 119.86 (+0.71), ISIS: 63.86 (-0.43), SIAL: 138.20 (+0.07), BASI: 2.06 (+0.18), MRK: 58.81 (-0.07), CGEN: 8.19 (+0.08), CRL: 73.61 (-0.33), CELGZ: 3.17 (-0.04), NVS: 102.20 (-0.17)
US Infectious Disease Molecular Diagnostics Market - Supplier Shares, Emerging Technologies & Competitive Landscape
M2 - Thu Aug 28, 5:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cp27n9/us_infectious) has announced the addition of the "US Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape" report to their offering. This new study contains 636 pages, 27 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. U.S. Market Overview: - Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases by market segment. - Five-year test volume and sales projections. Market Segmentation Analysis: - Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components. - Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays. - A comprehensive analysis of the sequencing market by country and laboratory segment. - Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers. Product/Technology Review: - Comparison of leading infectious disease molecular diagnostic analyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products. Opportunities and Strategic Recommendations: - Specific new product development opportunities with potentially significant market appeal during the next five years. - Design criteria for new products. - Alternative market penetration strategies. - Potential market entry barriers and risks. - Business planning issues and concerns. Competitive Profiles - Abbott - Affymetrix - Agilent Technologies - Beckman Coulter/Danaher - Becton Dickinson - BioMerieux - Bio-Rad - Caliper - Cepheid - Decode - Diadexus - Exact Sciences - Fujirebio/Innogenetics - Grifols - Hologic/Gen-Probe - Illumina - Kreatech - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Nanogen/Elitech - Qiagen - Roche - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group For more information visit http://www.researchandmarkets.com/research/cp...infectious
MYGN: 34.03 (+0.40), A: 40.15 (+0.13), DHR: 86.81 (+0.21), SQNM: 3.62 (unch), CPHD: 59.62 (+0.72), HOLX: 30.46 (+0.21)
Global Lab Automation Market - Forecast to 2020
M2 - Tue Aug 26, 10:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8v7q34/lab_automation) has announced the addition of the "Lab Automation Global Market - Forecast to 2020" report to their offering. The laboratory automation market is expected to grow at a CAGR rate of around 7.0% from 2014 to 2019 The factors that contributes for the market growth include rise in diagnosis owing to work pressure, shortage of quality lab technicians, accuracy of the results, budget constraints for laboratories, time delay and labor cost. However the changes in reimbursement policies, high cost of equipment, affordability by small players, users shift from traditional procedures to automation are hampering the growth of the market. Although, lack of flexibility and adoptability in the existing lab automated systems pose a threat for the market, there is a big need for the market to grow as latest diagnostic technologies demand for new and sophisticated automated systems in the coming years. New market segments such as automation options in microbiology and hematology are providing more opportunities for the market growth. North America holds the largest market share of laboratory automation process followed by Europe, Asia and rest of the world. U.S. tops the chart due to its aging population, high diagnosis rate, and large volume of test samples compelling the clinical diagnostic laboratories to shift for automation process. The emerging economies are the fastest growing in the market because of its growing economy, rising health care awareness and increasing investment in corporate and academic research. Key Topics Covered: 1. Executive summary 2. Introduction 3. Market Analysis 4. Laboratory Automation Market, by Applications 6. Laboratory Automation Market, By End Users 7. Laboratory Automation Market, By Hardware 8. Laboratory Automation Market, By Software 9. Geographic Analysis 10. Competitive Landscape 11. Company Profiles - Abbott Diagnostics - Agilent Technologies - Biotek Instruments, Inc. - Danaher Corp - Hamilton Robotics, Inc - Labware, Inc. - PerkinElmer, Inc. - Siemens Healthcare - Tecan Group Ltd - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/8v...automation
A: 40.15 (+0.13), DHR: 86.81 (+0.21), PKI: 46.30 (-0.10)
Tecan announces financial results for the first half of 2014 as well as successes in product and corporate development
Thomson Reuters ONE - Wed Aug 13, 12:00AM CDT
Tecan Group AG / Tecan announces financial results for the first half of 2014 as well as successes in product and corporate development . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
Sample Preparation Market by Product [Instruments, Consumables, Kits], Application & by End Users - Global Forecast to 2018
M2 - Fri Aug 08, 5:16AM CDT
Research and Markets (http://www.researchandmarkets.com/research/38xjl7/sample) has announced the addition of the "Sample Preparation Market by Product [Instruments, Consumables, Kits], Application & by End Users - Global Forecast to 2018" report to their offering. The sample preparation kits have the largest share in the global sample preparation market, since it has variety of applications in all areas which include molecular diagnostics, applied testing, pharmaceutical, biotechnology and biopharmaceuticals, academic research institutes etc. Molecular diagnostics accounted for the largest sample preparation application market the sample preparation instruments provide a fixed and validated protocols for sample preparation which a high requirement in molecular diagnostics field. In the years to come, the sample preparation market is expected to experience the highest growth in the Asian region with emphasis on China, and India. These countries will serve as new revenue pockets for sample preparation companies. The high growth in these regions can be attributed to the growing pharmaceutical and biotechnology industry, growing crop researches, increased funding scenario, and collaborations with established market players. Apart from Asia, countries such as Brazil, Mexico, and Africa are also projected to have significant growth in the sample preparation market. The U.S. and Europe are witnessing a steady growth owing to new applications in diagnostics fields, applied markets, and technological advancements in these regions. RoW includes regions such as Latin America, Africa, the Middle East, and the Pacific countries are experiencing increasing focus on research and gaining funds, thus increasing the potentiality for sample preparation market in these regions. Scope Product - Instruments (Workstations, Liquid Handling Systems) - Consumables (Tubes) - Kits (Isolation, Purification) Application - Genomics - Proteomics End Users - Molecular Diagnostics Companies Mentioned - Agilent Technologies, Inc. - Bio-Rad Laboratories, Inc. - Danaher Corporation - Hamilton Company - Illumina, Inc - Merck Millipore - Morgen Biotek Corporation - Perkinelmer, Inc. - Qiagen N.V. - Roche Applied Science - Sigma-Aldrich Corporation - Tecan Group Ltd. - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/38xjl7/sample
A: 40.15 (+0.13), SIAL: 138.20 (+0.07), MRK: 58.81 (-0.07), ILMN: 198.54 (+1.81), QGEN: 23.68 (-0.06), DHR: 86.81 (+0.21)
Tecan schedules conference call on August 13th to discuss half year 2014 financial results
Thomson Reuters ONE - Wed Aug 06, 2:23AM CDT
Tecan Group AG / Tecan schedules conference call on August 13th to discuss half year 2014 financial results . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
Tecan acquires IBL International to offer integrated solution for specialty diagnostics
Thomson Reuters ONE - Wed Jul 30, 12:15AM CDT
Tecan Group AG / Tecan acquires IBL International to offer integrated solution for specialty diagnostics . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
Global Laboratory Automation Systems Market Report 2014
M2 - Thu Jul 17, 5:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/xrfs4d/global_laboratory) has announced the addition of the "Global Laboratory Automation Systems Market Report 2014" report to their offering. The Global Laboratory Automation Systems market will grow at a CAGR of 5.32 percent over the period 2013-2018. Laboratory automation is the usage of technology and equipment to conduct routine or tedious activities including state-of-the-art work flows in research, quality assurance, and diagnostics laboratories. Automation enables robust and faster throughput and analysis of a large number of samples at one time. Laboratory automation systems are primarily used in clinical testing and drug discovery, and can either be standalone systems or total laboratory systems. This report covers the present scenario and the growth prospects of the Global Laboratory Automation Systems market for the period 2014-2018. To calculate the market size, the report considers revenue generated from the sales of laboratory automation systems such as: - Clinical Laboratory Systems - Drug Discovery Laboratory Systems The report also presents the vendor landscape and a corresponding detailed analysis of the top four vendors in the Global Laboratory Automation Systems market. In addition, the report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by vendors and the market at large as well as the key trends that are emerging in the market. The report, the Global Laboratory Automation Systems Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Laboratory Automation Systems market landscape. Key Vendors - Danaher Corp. - PerkinElmer Inc. - Tecan Group Ltd. - Thermo Fisher Scientific Inc. Other Prominent Vendors - Abbott Diagnostics - Agilent Technologies Inc. - Aurora Biomed Inc. - Becton, Dickinson and Co. - bioM?rieux SA - Biotek Instruments Inc. - Brooks Automation Inc. - Cerner Corp. - Eppendorf AG - Hamilton Storage Technologies Inc. - LabVantage Solutions Inc. - Labware Inc. - Olympus Corp. - Qiagen NV - Roche Holding AG - Sartorius Stedim-Biotech SA - Siemens Healthcare - Sotax AG - Xtril AG Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Application - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/xr...laboratory
A: 40.15 (+0.13), BRKS: 12.08 (+0.04), DHR: 86.81 (+0.21), PKI: 46.30 (-0.10), CERN: 70.98 (+1.15)
Tecan unveils new Fluent(TM) laboratory automation solutions
Thomson Reuters ONE - Tue Jun 24, 12:25AM CDT
Tecan Group AG / Tecan unveils new Fluent(TM) laboratory automation solutions . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
Global Sample Preparation Market 2014-2018 by Product (Instruments, Consumables, Kits), Application (Genomics, Proteomics) & End Users (Molecular Diagnostics)
M2 - Wed Jun 18, 9:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/kkk6xn/sample) has announced the addition of the "Global Sample Preparation Market 2014-2018 by Product (Instruments, Consumables, Kits), Application (Genomics, Proteomics) & End Users (Molecular Diagnostics)" report to their offering. The global sample preparation market is segmented on the basis of products, applications, and end users. Based on products the global market includes instruments, consumables, accessories and kits. Instruments are further classified into sample preparation workstations, liquid handling systems, extraction systems and others. Liquid handling systems comprises liquid handling workstations, pipetting systems, reagent dispensers, microplate washers and others. The consumables comprise filters, columns, tubes, plates and others. Accessories include caps, disposable bags/box, rod covers, adapters, tip and tube holder, plate carrier. Sample Preparation kits further segmented into Purification kits (DNA, RNA, Nucleic Acid and Protein), Extraction kits (DNA, RNA, Nucleic Acid and Protein), Isolation kits (DNA, RNA, Nucleic Acid and Protein), and others (Cell Lysis kits and Clean- up kits). Based on applications the global sample preparation market is broadly categorized into genomics, proteomics, epigenomics and others. Based on geography, the market is divided into North America, Europe, Asia, and the Rest of World (ROW). The market by end users segmented into molecular diagnostics, pharmaceuticals & biotechnology, applied testing, and academic research institutes. In 2013, the molecular diagnostics accounted for the largest share of the global market, by end users. A number of factors such as technological advancements in workstations, global alliances amongst leading research institutes to boost drug discovery, increasing life science and R&D spending, technological advancements in analytical instruments are propelling the growth of the sample preparation market. However, difficulty in developing one-size-fits-all' kits and high costs of workstations are the major factors hindering the growth of this market. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Sample Preparation Market, By Product 5 Sample Preparation Market, By Application 6 Sample Preparation Market, By End User 7 Sample Preparation Market, By Geography 8 Competitive Landscape 9 Company Profiles - Agilent Technologies, Inc. - Bio-Rad Laboratories, Inc. - Danaher Corporation - Hamilton Company - Illumina, Inc - Merck Millipore - Norgen Biotek Corporation - Perkinelmer, Inc. - Qiagen N.V. - Roche Applied Science - Sigma-Aldrich Corporation - Tecan Group Ltd. - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/kkk6xn/sample
A: 40.15 (+0.13), SIAL: 138.20 (+0.07), MRK: 58.81 (-0.07), ILMN: 198.54 (+1.81), QGEN: 23.68 (-0.06), DHR: 86.81 (+0.21)
Form 4: Update Filing for Boston Beer Inc (SAM)
Vickers Stock Research - Thu Feb 27, 7:06AM CST
Tecan Group AG / Tecan Group AG : Tecan schedules Analyst and Media Conference on March 7 to discuss Full-Year 2012 Financial Results . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement.
SAM: 303.26 (-0.97)
Tecan to present at J.P. Morgan Healthcare Conference
Thomson Reuters ONE - Thu Jan 08, 12:25AM CST
Tecan Group AG / Tecan to present at J.P. Morgan Healthcare Conference . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
JPM: 59.67 (+0.10)
2014-2018 US Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers
M2 - Mon Dec 08, 8:27AM CST
Research and Markets (http://www.researchandmarkets.com/research/vf9r39/20142018_us) has announced the addition of the "2014-2018 US Molecular Diagnostics Market: Sales and Market Shares of Major Suppliers" report to their offering. This unique report provides US sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Caliper - Cepheid - Decode - Diadexus - Eiken - Enzo - Exact Sciences - Grifols - Illumina - Kreatech - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Ortho-Clinical Diagnostics - Proteome Sciences - Qiagen - Roche - Takara Bio - Tecan Group For more information visit http://www.researchandmarkets.com/research/vf...0142018_us
MYGN: 34.03 (+0.40), A: 40.15 (+0.13), CPHD: 59.62 (+0.72), DHR: 86.81 (+0.21)
2014-2018 US Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers
M2 - Mon Dec 08, 8:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/mz6ptk/20142018_us) has announced the addition of the "2014-2018 US Nucleic Acid Testing/NAT Market: Sales and Market Shares of Major Suppliers" report to their offering. This unique report provides US sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Company Profiles - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Decode - Diadexus - Eiken - Enzo - Exact Sciences - Illumina - Kreatech - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Nanogen/Elitech - Orchid CellMark - Ortho-Clinical Diagnostics - Proteome Sciences - Qiagen - Roche - Siemens - Sierra Molecular - Takara Bio - Tecan Group For more information visit http://www.researchandmarkets.com/research/mz...0142018_us
MYGN: 34.03 (+0.40), A: 40.15 (+0.13), DHR: 86.81 (+0.21)
Tecan issues H2 2014 trading update
Thomson Reuters ONE - Mon Dec 01, 12:15AM CST
Tecan Group AG / Tecan issues H2 2014 trading update . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
Global High Throughput Screening (HTS) Market 2014-2018: Key Vendors are Agilent, Bio-Rad, Danaher, PerkinElmer, Sigma-Aldrich and Thermo Fisher
M2 - Thu Oct 09, 2:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qzqwwb/global_high) has announced the addition of the "Global High Throughput Screening (HTS) Market 2014-2018" report to their offering. High throughput screening (HTS) is a technology of screening and analyzing a large number of biological or chemical compounds against specific targets. It is generally a fully automated technology and involves instruments, consumables, and software for screening and analysis of compound. The use of liquid handling devices, robotics, and bioinformatics are important aspects of the HTS technology. It is widely used by researchers for drug discovery and other research applications. The high sensitivity, high speed, and easy to use supports the adoption of HTS in research and drug discovery to identify enzymes, ligands for receptors, ion-channels, or other pharmacological targets of interest. HTS is a crucial step in drug discovery for various applications such as assay development, target identification, and primary screening. The analysts forecast the Global HTS market to grow at a CAGR of 7.85 percent over the period 2013-2018. Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Market Segmentation by Application 08. Market Segmentation by Technology 09. Market Segmentation by Product 10. Geographical Segmentation 11. Buying Criteria 12. Market Growth Drivers 13. Drivers and their Impact 14. Market Challenges 15. Impact of Drivers and Challenges 16. Market Trends 17. Trends and their Impact 18. Vendor Landscape 19. Key Vendor Analysis Companies Mentioned: - Agilent Technologies - Aurora Biomed - Axxam - BMG LABTECH - Becton - Bio-Rad Laboratories - BioFocus DPI - BioTek Instruments - Brooks Automation - Charles River LaboratoriesInternational - Corning - Danaher - Dickinson and Company - DiscoveRx - Dynamic Devices - Evotec - F. Hoffmann-La Roche - Genedata - Intellicyt - Luminex - PerkinElmer - Sigma-Aldrich - Tecan Group - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/qz...lobal_high
A: 40.15 (+0.13), DHR: 86.81 (+0.21), PKI: 46.30 (-0.10)
European Major Molecular Diagnostic Product Suppliers Sales and Market Shares 2014
M2 - Mon Oct 06, 6:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cw28k8/europe_sales_and) has announced the addition of the "Europe Sales and Market Shares of Major Molecular Diagnostic Product Suppliers by Country" report to their offering. This unique report provides Europe sales and market share estimates for major suppliers of molecular diagnostic products by country. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca/Nuvelo - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Decode - Diadexus - Grifols - Hologic/Gen-Probe - Illumina - Kreatech - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group For more information visit http://www.researchandmarkets.com/research/cw..._sales_and
SQNM: 3.62 (unch), MYGN: 34.03 (+0.40), A: 40.15 (+0.13), DHR: 86.81 (+0.21), HOLX: 30.46 (+0.21)
Germany Major Molecular Diagnostic Product Suppliers Report 2014 - Sales and Market Shares Analysis
M2 - Mon Oct 06, 6:00AM CDT
Research and Markets (http://www.researchandmarkets.com/research/d86mxx/germany_sales_and) has announced the addition of the "Germany Sales and Market Shares of Major Molecular Diagnostic Product Suppliers" report to their offering. This unique report provides Germany sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Agilent Technologies - Applied Gene Technologies - Arca/Nuvelo - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Cepheid - Diadexus - Enzo - Exact Sciences - Fujirebio/Innogenetics - Grifols - Hologic/Gen-Probe - Illumina - Kreatech - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Nanogen/Elitech - Ortho-Clinical Diagnostics - Proteome Sciences - Qiagen - Roche - Siemens - Takara Bio - Tecan Group For more information visit http://www.researchandmarkets.com/research/d8..._sales_and
MYGN: 34.03 (+0.40), A: 40.15 (+0.13), DHR: 86.81 (+0.21), CPHD: 59.62 (+0.72), HOLX: 30.46 (+0.21)
Japan Major Molecular Diagnostic Product Suppliers Sales and Market Shares 2014
M2 - Fri Oct 03, 9:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zglr3w/japan_sales_and) has announced the addition of the "Japan Sales and Market Shares of Major Molecular Diagnostic Product Suppliers" report to their offering. This unique report provides Japan sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca/Nuvelo - Beckman Coulter/Danaher - Becton Dickinson - Biokit - BioMerieux - Bio-Rad - Biotest - Caliper - Exact Sciences - Fujirebio/Innogenetics - Grifols - Hologic/Gen-Probe - Illumina - Kreatech - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group For more information visit http://www.researchandmarkets.com/research/zg..._sales_and
SQNM: 3.62 (unch), A: 40.15 (+0.13), DHR: 86.81 (+0.21), HOLX: 30.46 (+0.21)
Tecan announces Capital Markets Day
Thomson Reuters ONE - Wed Sep 10, 12:30AM CDT
Tecan Group AG / Tecan announces Capital Markets Day . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
Drug Discovery Technologies - A Global Market Overview
M2 - Fri Aug 29, 5:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dtdx3f/drug_discovery) has announced the addition of the "Drug Discovery Technologies - A Global Market Overview" report to their offering. The development of new drugs for treating difficult diseases, such as cancer requires extensive expenditure, in addition to consuming a lot of time. The first step in designing a new drug involves the utilizing high-throughput screening of large chemical libraries for identifying compounds that can provide the requisite therapeutic effect. The capability of visualizing biological activity at the cellular level has constituted a strategic component in drug discovery, and adding automation and high-volume screening methods has enabled in testing compounds in large numbers. The field of pharmaceutical research is being provided considerable impetus through the combination of imaging and screening. Key Topics Covered: PART A: GLOBAL MARKET PERSPECTIVE 1. INTRODUCTION 2. KEY MARKET TRENDS 3. RECENT PATENTS IN DRUG DISCOVERY LANDSCAPE 4. KEY GLOBAL PLAYERS 5. KEY BUSINESS TRENDS 6. GLOBAL MARKET OVERVIEW PART B: REGIONAL MARKET PERSPECTIVE 1. THE UNITED STATES 2. EUROPE 3. ASIA-PACIFIC 4. REST OF WORLD PART C: GUIDE TO THE INDUSTRY 1. NORTH AMERICA 2. EUROPE 3. ASIA-PACIFIC 4. REST OF WORLD PART
ANNEXURE 1. RESEARCH METHOLOGY 2. FEEDBACK Companies Mentioned: - 4-Antibody AG - Abbott Laboratories - Accelrys, Inc. - Affymetrix Inc. - Agilent Technologies Inc. - Asahi Kasei Pharma Corporation - Astrazeneca Plc - Aviva Biosciences Corp. - Bayer Healthcare AG - BD Biosciences - Beckman Coulter Inc. - Biacore International AB - Bioanalytical Systems, Inc. - Bio-Rad Laboratories, Inc. - Boehringer Ingelheim GmbH - Bristol-Myers Squibb Company - Caliper Life Sciences, Inc. - Caprion Proteomics, Inc. - Celera Corporation - Celgene Corporation - Charles River Laboratories International, Inc. - Compugen Ltd. - Decode Genetics, Inc. - EMD Millipore Corporation - Evotec AG - GE Healthcare Ltd. - Genedata AG - Hitgen Ltd - Hudson Robotics, Inc. - Illumina Inc. - Incyte Corporation - Isis Pharmaceuticals, Inc. - Kyowa Hakko Kirin Co., Ltd. - Luminex Corporation - Maxcyte, Inc - Merck & Co., Inc. - Millennium Pharmaceuticals, Inc. - Molecular Devices, LLC - Molecular Discovery Ltd. - Molecular Discovery Systems Pty., Ltd. - New England Biolabs, Inc. - Novartis AG - Osiris Therapeutics Inc. - Perkinelmer, Inc. - Promega Corporation - Qiagen N.V. - Quantum Pharmaceuticals - Roche Holding AG - Shimadzu Corporation - Sigma-Aldrich Corporation - Sri Biosciences - Tecan Group Ltd. - The National Center for Drug Screening - Thermo Fisher Scientific Inc. - Viva Biotech Ltd - Waters Corp. For more information visit http://www.researchandmarkets.com/research/dt..._discovery A: 40.15 (+0.13), OSIR: 15.95 (+0.28), ILMN: 198.54 (+1.81), LMNX: 15.45 (+0.02), AFFX: 11.45 (+0.02), QGEN: 23.68 (-0.06), BCOR: 14.20 (-0.45), ACCL: 12.51 (+0.03), ABT: 46.09 (+0.87), INCY: 75.94 (+0.28), BMY: 60.04 (+0.56), WAT: 119.86 (+0.71), ISIS: 63.86 (-0.43), SIAL: 138.20 (+0.07), BASI: 2.06 (+0.18), MRK: 58.81 (-0.07), CGEN: 8.19 (+0.08), CRL: 73.61 (-0.33), CELGZ: 3.17 (-0.04), NVS: 102.20 (-0.17)
US Infectious Disease Molecular Diagnostics Market - Supplier Shares, Emerging Technologies & Competitive Landscape
M2 - Thu Aug 28, 5:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cp27n9/us_infectious) has announced the addition of the "US Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape" report to their offering. This new study contains 636 pages, 27 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years. The infectious disease molecular diagnostics market is one of the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. U.S. Market Overview: - Laboratories performing DNA sequencing and molecular diagnostic testing for infectious diseases by market segment. - Five-year test volume and sales projections. Market Segmentation Analysis: - Sales and market shares of leading suppliers of infectious disease molecular diagnostic reagent kits and components. - Five-year test volume and sales projections for over 40 infectious disease molecular diagnostic assays. - A comprehensive analysis of the sequencing market by country and laboratory segment. - Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers. Product/Technology Review: - Comparison of leading infectious disease molecular diagnostic analyzers. - Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods. - Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products. Opportunities and Strategic Recommendations: - Specific new product development opportunities with potentially significant market appeal during the next five years. - Design criteria for new products. - Alternative market penetration strategies. - Potential market entry barriers and risks. - Business planning issues and concerns. Competitive Profiles - Abbott - Affymetrix - Agilent Technologies - Beckman Coulter/Danaher - Becton Dickinson - BioMerieux - Bio-Rad - Caliper - Cepheid - Decode - Diadexus - Exact Sciences - Fujirebio/Innogenetics - Grifols - Hologic/Gen-Probe - Illumina - Kreatech - Li-Cor Biosciences - Life Technologies/Thermo Fisher - Monogram Biosciences - Myriad Genetics - Nanogen/Elitech - Qiagen - Roche - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group For more information visit http://www.researchandmarkets.com/research/cp...infectious
MYGN: 34.03 (+0.40), A: 40.15 (+0.13), DHR: 86.81 (+0.21), SQNM: 3.62 (unch), CPHD: 59.62 (+0.72), HOLX: 30.46 (+0.21)
Global Lab Automation Market - Forecast to 2020
M2 - Tue Aug 26, 10:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8v7q34/lab_automation) has announced the addition of the "Lab Automation Global Market - Forecast to 2020" report to their offering. The laboratory automation market is expected to grow at a CAGR rate of around 7.0% from 2014 to 2019 The factors that contributes for the market growth include rise in diagnosis owing to work pressure, shortage of quality lab technicians, accuracy of the results, budget constraints for laboratories, time delay and labor cost. However the changes in reimbursement policies, high cost of equipment, affordability by small players, users shift from traditional procedures to automation are hampering the growth of the market. Although, lack of flexibility and adoptability in the existing lab automated systems pose a threat for the market, there is a big need for the market to grow as latest diagnostic technologies demand for new and sophisticated automated systems in the coming years. New market segments such as automation options in microbiology and hematology are providing more opportunities for the market growth. North America holds the largest market share of laboratory automation process followed by Europe, Asia and rest of the world. U.S. tops the chart due to its aging population, high diagnosis rate, and large volume of test samples compelling the clinical diagnostic laboratories to shift for automation process. The emerging economies are the fastest growing in the market because of its growing economy, rising health care awareness and increasing investment in corporate and academic research. Key Topics Covered: 1. Executive summary 2. Introduction 3. Market Analysis 4. Laboratory Automation Market, by Applications 6. Laboratory Automation Market, By End Users 7. Laboratory Automation Market, By Hardware 8. Laboratory Automation Market, By Software 9. Geographic Analysis 10. Competitive Landscape 11. Company Profiles - Abbott Diagnostics - Agilent Technologies - Biotek Instruments, Inc. - Danaher Corp - Hamilton Robotics, Inc - Labware, Inc. - PerkinElmer, Inc. - Siemens Healthcare - Tecan Group Ltd - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/8v...automation
A: 40.15 (+0.13), DHR: 86.81 (+0.21), PKI: 46.30 (-0.10)
Tecan announces financial results for the first half of 2014 as well as successes in product and corporate development
Thomson Reuters ONE - Wed Aug 13, 12:00AM CDT
Tecan Group AG / Tecan announces financial results for the first half of 2014 as well as successes in product and corporate development . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
Sample Preparation Market by Product [Instruments, Consumables, Kits], Application & by End Users - Global Forecast to 2018
M2 - Fri Aug 08, 5:16AM CDT
Research and Markets (http://www.researchandmarkets.com/research/38xjl7/sample) has announced the addition of the "Sample Preparation Market by Product [Instruments, Consumables, Kits], Application & by End Users - Global Forecast to 2018" report to their offering. The sample preparation kits have the largest share in the global sample preparation market, since it has variety of applications in all areas which include molecular diagnostics, applied testing, pharmaceutical, biotechnology and biopharmaceuticals, academic research institutes etc. Molecular diagnostics accounted for the largest sample preparation application market the sample preparation instruments provide a fixed and validated protocols for sample preparation which a high requirement in molecular diagnostics field. In the years to come, the sample preparation market is expected to experience the highest growth in the Asian region with emphasis on China, and India. These countries will serve as new revenue pockets for sample preparation companies. The high growth in these regions can be attributed to the growing pharmaceutical and biotechnology industry, growing crop researches, increased funding scenario, and collaborations with established market players. Apart from Asia, countries such as Brazil, Mexico, and Africa are also projected to have significant growth in the sample preparation market. The U.S. and Europe are witnessing a steady growth owing to new applications in diagnostics fields, applied markets, and technological advancements in these regions. RoW includes regions such as Latin America, Africa, the Middle East, and the Pacific countries are experiencing increasing focus on research and gaining funds, thus increasing the potentiality for sample preparation market in these regions. Scope Product - Instruments (Workstations, Liquid Handling Systems) - Consumables (Tubes) - Kits (Isolation, Purification) Application - Genomics - Proteomics End Users - Molecular Diagnostics Companies Mentioned - Agilent Technologies, Inc. - Bio-Rad Laboratories, Inc. - Danaher Corporation - Hamilton Company - Illumina, Inc - Merck Millipore - Morgen Biotek Corporation - Perkinelmer, Inc. - Qiagen N.V. - Roche Applied Science - Sigma-Aldrich Corporation - Tecan Group Ltd. - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/38xjl7/sample
A: 40.15 (+0.13), SIAL: 138.20 (+0.07), MRK: 58.81 (-0.07), ILMN: 198.54 (+1.81), QGEN: 23.68 (-0.06), DHR: 86.81 (+0.21)
Tecan schedules conference call on August 13th to discuss half year 2014 financial results
Thomson Reuters ONE - Wed Aug 06, 2:23AM CDT
Tecan Group AG / Tecan schedules conference call on August 13th to discuss half year 2014 financial results . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
Tecan acquires IBL International to offer integrated solution for specialty diagnostics
Thomson Reuters ONE - Wed Jul 30, 12:15AM CDT
Tecan Group AG / Tecan acquires IBL International to offer integrated solution for specialty diagnostics . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
Global Laboratory Automation Systems Market Report 2014
M2 - Thu Jul 17, 5:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/xrfs4d/global_laboratory) has announced the addition of the "Global Laboratory Automation Systems Market Report 2014" report to their offering. The Global Laboratory Automation Systems market will grow at a CAGR of 5.32 percent over the period 2013-2018. Laboratory automation is the usage of technology and equipment to conduct routine or tedious activities including state-of-the-art work flows in research, quality assurance, and diagnostics laboratories. Automation enables robust and faster throughput and analysis of a large number of samples at one time. Laboratory automation systems are primarily used in clinical testing and drug discovery, and can either be standalone systems or total laboratory systems. This report covers the present scenario and the growth prospects of the Global Laboratory Automation Systems market for the period 2014-2018. To calculate the market size, the report considers revenue generated from the sales of laboratory automation systems such as: - Clinical Laboratory Systems - Drug Discovery Laboratory Systems The report also presents the vendor landscape and a corresponding detailed analysis of the top four vendors in the Global Laboratory Automation Systems market. In addition, the report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by vendors and the market at large as well as the key trends that are emerging in the market. The report, the Global Laboratory Automation Systems Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Laboratory Automation Systems market landscape. Key Vendors - Danaher Corp. - PerkinElmer Inc. - Tecan Group Ltd. - Thermo Fisher Scientific Inc. Other Prominent Vendors - Abbott Diagnostics - Agilent Technologies Inc. - Aurora Biomed Inc. - Becton, Dickinson and Co. - bioM?rieux SA - Biotek Instruments Inc. - Brooks Automation Inc. - Cerner Corp. - Eppendorf AG - Hamilton Storage Technologies Inc. - LabVantage Solutions Inc. - Labware Inc. - Olympus Corp. - Qiagen NV - Roche Holding AG - Sartorius Stedim-Biotech SA - Siemens Healthcare - Sotax AG - Xtril AG Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Application - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/xr...laboratory
A: 40.15 (+0.13), BRKS: 12.08 (+0.04), DHR: 86.81 (+0.21), PKI: 46.30 (-0.10), CERN: 70.98 (+1.15)
Tecan unveils new Fluent(TM) laboratory automation solutions
Thomson Reuters ONE - Tue Jun 24, 12:25AM CDT
Tecan Group AG / Tecan unveils new Fluent(TM) laboratory automation solutions . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.
Global Sample Preparation Market 2014-2018 by Product (Instruments, Consumables, Kits), Application (Genomics, Proteomics) & End Users (Molecular Diagnostics)
M2 - Wed Jun 18, 9:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/kkk6xn/sample) has announced the addition of the "Global Sample Preparation Market 2014-2018 by Product (Instruments, Consumables, Kits), Application (Genomics, Proteomics) & End Users (Molecular Diagnostics)" report to their offering. The global sample preparation market is segmented on the basis of products, applications, and end users. Based on products the global market includes instruments, consumables, accessories and kits. Instruments are further classified into sample preparation workstations, liquid handling systems, extraction systems and others. Liquid handling systems comprises liquid handling workstations, pipetting systems, reagent dispensers, microplate washers and others. The consumables comprise filters, columns, tubes, plates and others. Accessories include caps, disposable bags/box, rod covers, adapters, tip and tube holder, plate carrier. Sample Preparation kits further segmented into Purification kits (DNA, RNA, Nucleic Acid and Protein), Extraction kits (DNA, RNA, Nucleic Acid and Protein), Isolation kits (DNA, RNA, Nucleic Acid and Protein), and others (Cell Lysis kits and Clean- up kits). Based on applications the global sample preparation market is broadly categorized into genomics, proteomics, epigenomics and others. Based on geography, the market is divided into North America, Europe, Asia, and the Rest of World (ROW). The market by end users segmented into molecular diagnostics, pharmaceuticals & biotechnology, applied testing, and academic research institutes. In 2013, the molecular diagnostics accounted for the largest share of the global market, by end users. A number of factors such as technological advancements in workstations, global alliances amongst leading research institutes to boost drug discovery, increasing life science and R&D spending, technological advancements in analytical instruments are propelling the growth of the sample preparation market. However, difficulty in developing one-size-fits-all' kits and high costs of workstations are the major factors hindering the growth of this market. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Sample Preparation Market, By Product 5 Sample Preparation Market, By Application 6 Sample Preparation Market, By End User 7 Sample Preparation Market, By Geography 8 Competitive Landscape 9 Company Profiles - Agilent Technologies, Inc. - Bio-Rad Laboratories, Inc. - Danaher Corporation - Hamilton Company - Illumina, Inc - Merck Millipore - Norgen Biotek Corporation - Perkinelmer, Inc. - Qiagen N.V. - Roche Applied Science - Sigma-Aldrich Corporation - Tecan Group Ltd. - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/kkk6xn/sample
A: 40.15 (+0.13), SIAL: 138.20 (+0.07), MRK: 58.81 (-0.07), ILMN: 198.54 (+1.81), QGEN: 23.68 (-0.06), DHR: 86.81 (+0.21)
Form 4: Update Filing for Boston Beer Inc (SAM)
Vickers Stock Research - Thu Feb 27, 7:06AM CST
Tecan Group AG / Tecan Group AG : Tecan schedules Analyst and Media Conference on March 7 to discuss Full-Year 2012 Financial Results . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement.
SAM: 303.26 (-0.97)
